JP2016146837A5 - - Google Patents

Download PDF

Info

Publication number
JP2016146837A5
JP2016146837A5 JP2016041230A JP2016041230A JP2016146837A5 JP 2016146837 A5 JP2016146837 A5 JP 2016146837A5 JP 2016041230 A JP2016041230 A JP 2016041230A JP 2016041230 A JP2016041230 A JP 2016041230A JP 2016146837 A5 JP2016146837 A5 JP 2016146837A5
Authority
JP
Japan
Prior art keywords
seq
recombinant adenovirus
protein
recombinant
immunogenic epitope
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016041230A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016146837A (ja
JP6293181B2 (ja
Filing date
Publication date
Priority claimed from PCT/US2009/054212 external-priority patent/WO2011022002A1/en
Application filed filed Critical
Publication of JP2016146837A publication Critical patent/JP2016146837A/ja
Publication of JP2016146837A5 publication Critical patent/JP2016146837A5/ja
Application granted granted Critical
Publication of JP6293181B2 publication Critical patent/JP6293181B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016041230A 2009-08-18 2016-03-03 免疫原性マラリア原虫周辺スポロゾイトタンパク質エピトープによる組換えアデノウイルスの改変 Expired - Fee Related JP6293181B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
USPCT/US2009/054212 2009-08-18
PCT/US2009/054212 WO2011022002A1 (en) 2009-08-18 2009-08-18 Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012525677A Division JP5947719B2 (ja) 2009-08-18 2010-08-18 免疫原性マラリア原虫周辺スポロゾイトタンパク質エピトープによる組換えアデノウイルスの改変

Publications (3)

Publication Number Publication Date
JP2016146837A JP2016146837A (ja) 2016-08-18
JP2016146837A5 true JP2016146837A5 (enExample) 2017-02-16
JP6293181B2 JP6293181B2 (ja) 2018-03-14

Family

ID=43607237

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012525677A Expired - Fee Related JP5947719B2 (ja) 2009-08-18 2010-08-18 免疫原性マラリア原虫周辺スポロゾイトタンパク質エピトープによる組換えアデノウイルスの改変
JP2016041230A Expired - Fee Related JP6293181B2 (ja) 2009-08-18 2016-03-03 免疫原性マラリア原虫周辺スポロゾイトタンパク質エピトープによる組換えアデノウイルスの改変

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2012525677A Expired - Fee Related JP5947719B2 (ja) 2009-08-18 2010-08-18 免疫原性マラリア原虫周辺スポロゾイトタンパク質エピトープによる組換えアデノウイルスの改変

Country Status (16)

Country Link
US (1) US20170348405A1 (enExample)
EP (2) EP3412306A3 (enExample)
JP (2) JP5947719B2 (enExample)
KR (1) KR20120094469A (enExample)
CN (2) CN105770880A (enExample)
BR (1) BR112012003808A2 (enExample)
CA (1) CA2769415A1 (enExample)
IL (1) IL217709A (enExample)
MX (1) MX339830B (enExample)
NZ (1) NZ598703A (enExample)
PH (1) PH12012500164A1 (enExample)
RU (1) RU2585228C2 (enExample)
SG (2) SG10201404970PA (enExample)
UA (1) UA108081C2 (enExample)
WO (2) WO2011022002A1 (enExample)
ZA (1) ZA201201286B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9115205B2 (en) 2010-10-18 2015-08-25 The United States Of America, As Represented By The Secretary Of The Army Plasmodium falciparum circumsporozoite vaccine gene optimization for soluble protein expression
US20120244178A1 (en) * 2011-03-25 2012-09-27 Denise Doolan Plasmodium falciparum antigens
KR102089121B1 (ko) 2013-03-14 2020-03-13 더 솔크 인스티튜트 포 바이올로지칼 스터디즈 종양살상형 아데노바이러스 조성물
EP3004348B1 (en) * 2013-06-03 2023-03-08 VLP Therapeutics, Inc. Malaria vaccine
EP3198009B1 (en) 2014-09-24 2021-09-08 Salk Institute for Biological Studies Oncolytic tumor viruses and methods of use
AU2016322544B2 (en) * 2015-09-16 2022-08-25 Artificial Cell Technologies, Inc. Anti-malaria compositions and methods
LT3405582T (lt) 2016-01-21 2020-12-10 Janssen Vaccines & Prevention B.V. Patobulinta vakciną nuo maliarijos adenoviruso, koduojančio ir eksponuojančio maliarijos antigeną, pagrindu
JP7015551B2 (ja) 2016-02-23 2022-02-15 ソーク インスティテュート フォー バイオロジカル スタディーズ ウイルス動態への影響を最小限にするための治療用アデノウイルスにおける外因性遺伝子発現
EP3390428B1 (en) 2016-02-23 2019-09-25 Salk Institute for Biological Studies High throughput assay for measuring adenovirus replication kinetics
CN107841513B (zh) * 2016-09-18 2023-04-14 中国科学院上海巴斯德研究所 基于M2e表位的广谱型流感疫苗
JP7794421B2 (ja) 2016-12-12 2026-01-06 ソーク インスティテュート フォー バイオロジカル スタディーズ 腫瘍を標的にする合成アデノウイルスおよびその使用
CN108192876A (zh) * 2017-12-07 2018-06-22 东莞市第八人民医院 一种人3型腺病毒衣壳蛋白同时展示ca16双中和抗原表位疫苗候选株的制备方法和应用
BR112020019942A2 (pt) 2018-04-09 2021-01-26 Salk Institute For Biological Studies composições de adenovírus oncolítico com propriedades de replicação aprimoradas
WO2020221451A1 (en) * 2019-04-30 2020-11-05 Humabs Biomed Sa Antibodies binding to plasmodium circumsporozoite protein and uses thereof
CN110687289B (zh) * 2019-10-17 2023-04-18 中国人民解放军陆军军医大学 Fgl2蛋白作为疟疾感染标志物的应用
GB201915905D0 (en) * 2019-11-01 2019-12-18 Spybiotech Ltd Viruses with modified capsid proteins
JP2021178021A (ja) * 2020-05-14 2021-11-18 株式会社三洋物産 遊技機
WO2022234276A1 (en) * 2021-05-04 2022-11-10 SpyBiotech Limited Adenoviral vectors and vaccines thereof
JP2024536835A (ja) * 2021-09-23 2024-10-08 サジタリウス バイオ,インコーポレーテッド アデノウイルス及びアデノウイルスの使用方法
CN120944926B (zh) * 2025-10-15 2026-01-30 华中科技大学同济医学院附属同济医院 衣壳表面展示超大片段抗原的重组腺病毒、构建方法及应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6066623A (en) * 1993-11-23 2000-05-23 The United States Of America As Represented By The Secretary Of The Navy Polynucleotide vaccine protective against malaria, methods of protection and vector for delivering polynucleotide vaccines
AU2002327338A1 (en) * 2001-07-25 2003-02-17 New York University Use of glycosylceramides as adjuvants for vaccines against infections and cancer
PL376792A1 (pl) * 2002-10-23 2006-01-09 Glaxosmithkline Biologicals S.A. Sposoby szczepienia przeciwko malarii
WO2004055187A1 (en) * 2002-12-17 2004-07-01 Crucell Holland B.V. Recombinant viral-based malaria vaccines
CA2524499A1 (en) * 2003-05-14 2004-11-25 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa Broadening adenovirus tropism
JP2005287309A (ja) * 2004-03-31 2005-10-20 Dnavec Research Inc 遺伝子導入を増強するための薬剤および方法
CN101072879B (zh) * 2004-10-13 2011-05-11 克鲁塞尔荷兰公司 改良的腺病毒载体及其应用
WO2007027860A2 (en) * 2005-08-31 2007-03-08 Genvec, Inc. Adenoviral vector-based malaria vaccines
US20100272753A1 (en) * 2006-10-26 2010-10-28 The Johns Hopkins University Recombinant Adenovirus Vaccines

Similar Documents

Publication Publication Date Title
JP2016146837A5 (enExample)
SG156535A1 (en) Recombinant viral-based malaria vaccines
UA108081C2 (uk) Модифікація рекомбінантного аденовірусу імуногенними епітопами білка circumsporozoite плазмодія
IL182357A0 (en) Malaria prime/boost vaccines
MX2020000221A (es) Secuencias de aminoacidos y de acidos nucleicos de adenovirus de grandes simios no humanos, vectores que contienen las mismas y usos de las mismas.
JP2016539946A5 (enExample)
JP2019519252A5 (enExample)
EA200901060A1 (ru) Новый способ и композиции
JP2015096070A5 (enExample)
JP2017035093A5 (enExample)
JP2012501959A5 (enExample)
JP2020536489A5 (enExample)
JP2013507907A5 (enExample)
WO2011138251A8 (en) Lentiviral vector based immunological compounds against malaria
JP2014507146A5 (enExample)
WO2014205579A4 (en) Modified matrix proteins of vesicular stomatitis virus
Schöne et al. Immunodominance of adenovirus-derived CD8+ T cell epitopes interferes with the induction of transgene-specific immunity in adenovirus-based immunization
JP2010532656A5 (enExample)
JP2014519817A5 (enExample)
ZA201707985B (en) Recombinant modified vaccinia virus ankara (mva) foot and mouth disease virus (fmdv) vaccine
JP2020509770A5 (enExample)
WO2008086386A3 (en) Adenoviral vector-based malaria vaccines
JP2018533908A5 (enExample)
PH12018502430A1 (en) Vaccines
WO2012042279A3 (en) Viral vector immunogenic compositions